Soft Tissue Sarcoma—Health Professional Version
Soft tissue sarcomas are malignant tumors that arise in any of the mesodermal tissues of the extremities, trunk and retroperitoneum, or head and neck. Soft tissue sarcomas may be heterogeneous. Find evidence-based information on soft tissue sarcoma treatment and research.
View a list of clinical trials for soft tissue sarcoma or use the clinical trials search tool to find other trials and refine your results with filters.
Adult Soft Tissue Sarcoma Treatment
-
Soft Tissue Sarcoma Treatment (PDQ®)
Get detailed information for newly diagnosed and recurrent STS and treatment in this summary for clinicians.
-
Gastrointestinal Stromal Tumors Treatment (PDQ®)
Get detailed information about the diagnosis, prognosis, and treatment of newly diagnosed and recurrent GISTs in this summary for clinicians.
-
Kaposi Sarcoma Treatment (PDQ®)
Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent Kaposi sarcoma in this summary for clinicians.
Childhood Soft Tissue Sarcoma Treatment
-
Childhood Soft Tissue Sarcoma Treatment (PDQ®)
Get detailed information about the treatment of newly diagnosed, metastatic, and recurrent soft tissue sarcoma in this summary for clinicians.
-
Childhood Gastrointestinal Stromal Tumors Treatment (PDQ®)
Get detailed information on pediatric gastrointestinal stromal tumors (GIST), including clinical and molecular features and treatment, in this summary for clinicians.
-
Childhood Rhabdomyosarcoma Treatment (PDQ®)
Get detailed information on pediatric embryonal, alveolar, and anaplastic rhabdomyosarcoma, including disease presentation, diagnosis, prognosis, treatment regimens, and clinical trials, in this summary for clinicians.
-
Childhood Vascular Tumors Treatment (PDQ®)
Get detailed information on childhood vascular tumors, including tumor types, treatment options, and palliative therapies, in this summary for clinicians.
Drugs Approved for Soft Tissue Sarcomas
-
Drugs Approved for Soft Tissue Sarcoma
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for soft tissue sarcoma.
-
Drugs Approved for Rhabdomyosarcoma
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for rhabdomyosarcoma.
-
Drugs Approved for Gastrointestinal Stromal Tumors
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for gastrointestinal stromal tumors (GIST).
-
Drugs Approved for Kaposi Sarcoma
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for Kaposi sarcoma.
Genetics
-
Rhabdoid Tumor Predisposition Syndrome Type 1 (PDQ®)
Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS1) is a hereditary cancer syndrome associated with the SMARCB1 gene. Learn about RTPS1's clinical features and management.
-
Rhabdoid Tumor Predisposition Syndrome Type 2 (PDQ®)
Rhabdoid Tumor Predisposition Syndrome Type 2 (RTPS2) is a hereditary cancer syndrome associated with the SMARCA4 gene. Learn about RTPS2's clinical features and management.
-
Childhood Cancer Genomics (PDQ®)
Get detailed information about various genetic alterations and precision medicine concepts in childhood cancers in this summary for clinicians.